http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a14885c81a2a0ffdb20616fe69531f23
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Gong |
| name | Yun Gong |
| given-name | Yun |
| organization-name | Zhuzhou Qianjin Pharmaceutical Co., Ltd. Zhuzhou P. R. China Department of Pathology, M.D. Anderson Cancer Center, USA. Department of Endocrinology,Sir Run Run Shaw Hospital,Zhejiang University School of Medicine,Hangzhou 310000,China. Tulane University Authors' Affiliations: Departments of 1Breast Medical Oncology, 2Bioinformatics and Computational Biology, and 3Pathology, The University of Texas M.D. Anderson Cancer Center; 4Lyndon B Johnson General Hospital, and The University of Texas Health Science Center, Houston, Texas; 5Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru; 6Grupo Español de Investigacion en Cancer de Mama, Madrid, Spain; and 7Centro Medico Nacional de Occidente, Guadalajara, Mexico 5Pathology, University of Texas M.D. Anderson Cancer Center, Houston, Texas; and NHC Key Laboratory of Birth Defects for Research and Prevention, Hunan Provincial Maternal and Child Health Care Hospital, Changsha, Hunan, China; Key Laboratory of Genetics and Birth Health, Family Planning Research Institute of Hunan Province, Changsha, Hunan, China Department of Applied Chemistry; College of Chemistry and Chemical Engineering; Chongqing University; Chongqing 400030, P. R. China Department of Pathology, UT MD Anderson Cancer Center Houston, TX, USA. 1Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston Department of Chemistry, The Ohio State University, Columbus, Ohio 43210 Department of Pathology, Unit 53, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA. Tel.: ; Fax: ; E-mail: yungong@mdanderson.org. Department of Pathology, M. D. Anderson Cancer Center, Houston, TX; Tulane Center of Biomedical Informatics and Genomics Deming Department of Medicine Tulane University School of Medicine Tulane University New Orleans LA USA Department of Pathology Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center Houston Texas 4Pathology, The University of Texas, M. D. Anderson Cancer Center, and Health Management Center Jiangxi Provincial People's Hospital (The First Affiliated Hospital of Nanchang Medical College) Nanchang China Department of Chemistry, Beijing Institute of Technology, Beijing 100081, P. R. China, Department of Applied Chemistry, Chongqing University, Chongqing 400044, P. R. China, and Department of Chemistry, Logistical Engineering University, Chongqing 400016, P. R. China From the Departments of Breast Medical Oncology and Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX; National Surgical Adjuvant Breast and Bowel Project Biostatistical Center; the Departments of Biostatistics and Pathology, University of Pittsburgh, Pittsburgh, PA; the Department of Pathology, Albany Medical College, Albany, NY; Department of Gynecologic Oncology Hopital Tenon, Paris; and the Translational Research Unit, Institute Gustave Roussy, Villejuif, France. 2The University of Texas M.D. Anderson Cancer Center, Houston. From the Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston (Gong). Department of Pathology Unit 53, The University of Texas M. D. Anderson Cancer Center Houston Texas USA From the Departments of Pathology (Dr Guo, Ms Khanna, and Drs Wang, Williams, Kalhor, Gong, and Staerkel), Head and Neck Surgery (Drs Xu and Sturgis), and Epidemiology (Dr Sturgis), The University of Texas MD Anderson Cancer Center, Houston. Tulane Center of Biomedical Informatics and Genomic, Deming Department of Medicine, School of Medicine, Tulane University The University of Texas MD Anderson Cancer Center, Houston, TX University of Texas, Department of Pathology, Anderson Cancer Center, Unit 53, 1515 Holcombe Blvd, Houston, TX 77030, USA. Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston; Department of Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston Health Management Center, Jiangxi Provincial People’s Hospital (the First Affiliated Hospital of Nanchang Medical College), Nanchang, Jiangxi 330006, China d Departments of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA Department of Pathology The University of Texas MD Anderson Cancer Center Houston Texas Qianjin Pharmaceutical Co. Ltd. Zhuzhou P.R. China School of Materials Science and Engineering; University of Shanghai for Science and Technology; Shanghai 200093; China Cavendish Laboratory, Department of Physics, University of Cambridge, J. J. Thomson Avenue, Cambridge, CB3 0HE, United Kingdom Department of Pathology Unit 53 The University of Texas M. D. Anderson Cancer Center Houston Texas 77030 Department of Applied Chemistry, College of Chemistry and Chemical Engineering, Chongqing University, Chongqing 400030, People's Republic of China Department of Otorhinolaryngology, West China Hospital, Sichuan University, Chengdu 610041, China. gonger_2000@yahoo.com.cn Key Laboratory for Renewable Energy (CAS), Beijing Key Laboratory for New Energy Materials and Devices, Institute of Physics, Chinese Academy of Sciences, Beijing, 100190, People’s Republic of China Naoki Niikura, Jun Liu, Naoki Hayashi, Elizabeth A. Mittendorf, Yun Gong, Shana L. Palla, Ana M. Gonzalez-Angulo, Gabriel N. Hortobagyi, and Naoto T. Ueno, The University of Texas MD Anderson Cancer Center, Houston, TX; and Naoki Niikura and Yutaka Tokuda, Tokai University School of Medicine, Kanagawa, Japan. Department of Pathology The University of Texas MD Anderson Cancer Center Houston TX USA Key Laboratory for Renewable Energy, Chinese Academy of Sciences, Beijing Key Laboratory for New Energy Materials and Devices, Beijing National Laboratory for Condensed Matter Physics, Institute of Physics, Chinese Academy of Sciences, Beijing 100190, PR China Department of Pathology, †Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030; Tulane Center of Biomedical Informatics and Genomics, Deming Department of Medicine, Tulane University School of Medicine, New Orleans, LA, USA Department of Pathology The University of Texas MD Anderson Cancer Center Houston Texas; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic The University of Texas MD Anderson Cancer Center Houston Texas From the Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston (Drs Diaz De Vivar, Gong, Staerkel, and Guo, Mss Dawlett and Jack, and Mr Wang); and the Department of Pathology, Texas Children's Hospital Pavilion for Women, Houston (Dr Diaz De Vivar). Department of Pathology, Unversity of Texas M.D. Anderson Cancer Center, Houston, Tx 77030, USA. yungong@mdanderson.org 1Department of Pathology and Laboratory Medicine, The University of Texas Health Science Center at Houston, TX, and the Department of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston Tulane Center of Biomedical Informatics and Genomics, Deming Department of Medicine, School of Medicine, Tulane University, New Orleans, LA 70112, USA Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA School of Materials Science and Engineering Nanjing Institute of Technology 211167 Nanjing P. R. China Tulane Center for Biomedical Informatics and Genomics, Deming Department of Medicine, School of Medicine, Tulane University, New Orleans, LA 70112, USA Cavendish Laboratory, University of Cambridge, J. J. Thomson Avenue, Cambridge, CB3 0HE, United Kingdom Authors' Affiliations: 1Department of Breast Medical Oncology, 2Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, Departments of 3Molecular and Cellular Oncology, 4Pathology, 5Radiation Oncology, and 6Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas; 7Tolero Pharmaceuticals, Inc., Salt Lake City, Utah; and 8Center for Molecular Medicine and Graduate Institute of Cancer Biology, China Medical University, Taichung, Taiwan; Authors' Affiliations: 1Department of Breast Medical Oncology, 2Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, Departments of 3Molecular and Cellular Oncology, 4Pathology, 5Radiation Oncology, and 6Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas; 7Tolero Pharmaceuticals, Inc., Salt Lake City, Utah; and 8Center for Molecular Medicine and Graduate Institute of Cancer Biology, China Medical University, Taichung, Taiwan From the Department of Pathology, Northwestern University Medical School, Chicago, Ill Division of Pathology and Laboratory Medicine, Department of Pathology The University of Texas MD Anderson Cancer Center Houston Texas Cavendish Laboratory; Department of Physics; University of Cambridge; Cambridge; UK Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA School of Materials and Chemistry, University of Shanghai for Science and Technology, 516 Jungong Road, Shanghai 200093, P.R. China From the Departments of Pathology (Drs Gong, Sun, and Chou) and Plastic Surgery (Drs Chao and Bauer), Children's Memorial Hospital, Northwestern University Medical Center, Chicago, Ill Departments of Pathology From the Department of Pathology, Northwestern University Medical School (Drs Gong, Sun, Haines, and Pins), and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University (Drs Haines and Pins), Chicago, Ill School of Materials and Chemistry, University of Shanghai for Science and Technology, Shanghai 200093, China Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Department of Applied Chemistry; College of Chemistry and Chemical Engineering; Chongqing University; Chongqing 400030; P. R. China MD Anderson Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA Department of Pathology the University of Texas MD Anderson Cancer Center Houston Texas Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX; |
Incoming Links
Total number of triples: 319.